PSEN1 and Alzheimer disease: Transgenic mouse models have also provided evidence reporting increased cognitive impairments, impaired hippocampal neurogenesis and increased AD-type pathologies in female, as compared to male, transgenic amyloid precursor protein × presenilin 1 (APPxPS1) mouse models of AD (e.g., [87,88]).